Motorola Solutions Inc vs Zimmer Biomet Holdings Inc — how do they compare? Motorola Solutions Inc trades at $468.74 (market cap $77.26B), while Zimmer Biomet Holdings Inc trades at $97.14 (market cap $18.55B). The key difference: Motorola Solutions Inc is far larger — about 4.2× Zimmer Biomet Holdings Inc's market cap, and Motorola Solutions Inc pays the higher dividend (1.04%). Which is the better fit depends on your goals.
| MSI | ZBH | |
|---|---|---|
Market Cap | $77.26B | $18.55B |
Sector | Technology | Health |
52-Week High | $490.30 | $107.71 |
52-Week Low | $363.83 | $79.58 |
Enterprise Value | $86.17B | $25.61B |
Dividend Yield | 1.04% | 0.99% |
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $468.70, up 1.45% on the day, reflecting strong momentum after Q2 2026 earnings beat estimates. The stock shows bullish technical signals with a golden cross pattern and is near its pivot point of $467. Fundamentally, revenue grew 13% year-over-year in Q2, with record backlog of $15.6 billion driving raised full-year guidance. Valuation ratios remain elevated with a P/E of 36.79, while profitability is robust with a net margin of 17.44% and ROE of 91.98%.
Outlook is positive given strong demand in public safety segments and upward earnings revisions, but risks include high valuation sensitivity and execution challenges. The consensus price target of $533.80 implies ~14% upside, supported by 71% analyst buy ratings. Investors should weigh growth prospects against premium multiples and monitor cash flow trends amid significant investing outflows.
ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.
The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.
Trailing returns across standard periods
Latest headlines on both assets
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →